Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.

Nephrol Dial Transplant

Published: July 2017

Download full-text PDF	Source
http://dx.doi.org/10.1093/ndt/gfx079	DOI Listing

Publication Analysis

multicenter open-label

open-label extension

extension trial

trial evaluate

evaluate long-term

long-term efficacy

efficacy safety

safety early

early versus

versus delayed

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!